Fig. 2.
Fig. 2. Elimination of allogeneic donor cells in the absence of CD4+ cells. / To test if optimal recipient CD8+ and B-cell responses required help from CD4+ cells, C57BL/6 and DBA/2 mice were injected with anti-CD4 on days −3 and −2. Then on day 0 these mice were either used as source of donor cells or as recipients. Detectable levels of anti-CD4 could be maintained in the recipient mice for at least 10 days with this protocol. The CD4−donor splenocytes were labeled with FITC and then injected into the recipients which had also been injected with anti-CD4. Persistence of donor cells was measured in the spleen (shown) and lymph nodes on days 3, 5, 6, and 7 (mean of 3 mice per time point for DBA/2 into DBA/2 [□] and C57BL/6 into DBA/2 [◊] combinations and a mean of 2 mice per time point for the DBA/2 into C57BL/6 [○] combinations are shown).

Elimination of allogeneic donor cells in the absence of CD4+ cells.

To test if optimal recipient CD8+ and B-cell responses required help from CD4+ cells, C57BL/6 and DBA/2 mice were injected with anti-CD4 on days −3 and −2. Then on day 0 these mice were either used as source of donor cells or as recipients. Detectable levels of anti-CD4 could be maintained in the recipient mice for at least 10 days with this protocol. The CD4donor splenocytes were labeled with FITC and then injected into the recipients which had also been injected with anti-CD4. Persistence of donor cells was measured in the spleen (shown) and lymph nodes on days 3, 5, 6, and 7 (mean of 3 mice per time point for DBA/2 into DBA/2 [□] and C57BL/6 into DBA/2 [◊] combinations and a mean of 2 mice per time point for the DBA/2 into C57BL/6 [○] combinations are shown).

Close Modal

or Create an Account

Close Modal
Close Modal